Global Inflation Device Market is growing at a steady CAGR of 4.5% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.
Access Full Report at https://www.databridgemarketresearch.com/jp/reports/global-inflation-device-market
The global Inflation Device market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to growing demand for the Inflation Device, booming across healthcare, technological advancements of global Inflation Device introduction of novel automated systems. The market has witness developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative monitoring technology in Inflation Device.
For instance, in September 2016, Acclarent, Inc. launched ACCLARENT AERA, an Eustachian tube balloon dilation system. This system offers minimally-invasive preference to treat the Eustachian tube dysfunction (ETD). This product proved beneficial for the otolaryngologists with its MIS option & strengthen the company’s’ product portfolio.
BD dominated the global inflation device market. The other key players existing in the market includes Medtronic, Boston Scientific Corporation, Teleflex, Olympus Corporation, B. Braun Melsungen AG, among others.
BD
BD headquartered in New Jersey, U.S. was founded in 1897. The company focuses on the development, manufacturing and sales of medical supplies, devices, laboratory equipment and diagnostic products. BD has multiple segments such as medical, life sciences, interventional, in this medical is the market focused segment. The company has wide range of product categories such as product catalog, access grafts, dialysis catheters, drug delivery, endoavf, enteral feeding, patches, fabrics, felts, pledgets, tapes, patient monitoring systems, stents & stent grafts, surgical grafts, vascular occlusion, vascular patency. The company is continuously engaged in strategic relationship to enhance the product and service of the inflation devices such as,
- In December 2017, BD acquired C. R. Bard, Inc. company which is engaged in health care industry. The acquisition created a pioneer leader in the treatment and procedures for patients and for health care providers respectively. This acquisition definitely creates the global healthcare leader.
The company has various subsidiaries such as CareFusion (U.S.), C. R. Bard (U.S), Accuri Cytometers Inc. (U.S.), TVA Medical, Inc. (U.S.), Becton Dickinson AcuteCare Inc. (West Africa), TriPath Imaging, Inc. (U.S.), and others.
Medtronic
Medtronic headquartered in Dublin, Ireland was founded in 1949. The company is engaged in offering a wide range of product portfolio for healthcare sectors around the world. Medtronic has multiple segments such as cardiac and vascular group, minimally invasive therapies group, restorative therapies group, diabetes group, in this cardiac and vascular group is the market focused segment. The company has wide range of product category such as advanced surgical technology, cardiac rhythm, cardiovascular, diabetes, digestive & gastrointestinal, ear, nose & throat, general surgery , neurological, oral maxillofacial & dental, patient monitoring, renal care, respiratory, spinal & orthopedic, tumor management, urological & women’s health, in this cardiovascular is the market focused product category.
The company has various subsidiaries such as Covidien (Dublin), Titan Spine, Inc. (U.S.), Given Imaging (Israel), Nutrino Health Ltd (Israel), TyRx Pharma Inc. (U.S.), and others.
Boston Scientific Corporation
Boston Scientific Corporation headquartered in Massachusetts, U.S. was founded in 1979. The company is focused on manufacture and sales of precision machineries and instruments. Boston Scientific Corporation has multiple segments such as cardiovascular, rhythm management, medsurg, in this cardiovascular is the market focused segment. The company has wide range of product portfolio such as access device: dilatation, access device: sheath, accessories, antiretropulsion, artificial urinary, sphincter, atherectomy systems, balloons: cutting, balloons: dilation and extraction, band ligator, baskets, bronchial thermoplasty, capital equipment: diagnostic, capital equipment: mapping & navigation, capital equipment: therapy, catheters: ablation, catheters: balloon, catheters: diagnostic, catheters: drainage, catheters: guide, catheters: mapping, catheters: ureteral, clips, coronary stents, crt-d, crt-p, cto systems, cytology brushes, deep brain stimulation systems, defibrillators (ICD), direct visualization systems, embolic protection, embolization, endoluminal surgery devices, endometrial ablation system, enteral access & feeding tubes, exchange device, FFR & Ivus systems, fiducial markers, forceps, guidewires, infection prevention, introducer sheaths, laser fibers & accessories, lasers, bph & lithotripsy, leads, left atrial appendage closure device, lifting agents, microcatheters, needles, pacemakers, pcnl, pelvic floor reconstruction, penile prosthesis, plaque modification, probes, radiofrequency ablation for pain management, remote patient monitoring and diagnostic monitoring, renal denervation, retrieval devices, RF ablation, slings: mid-urethral, slings: suburethral, snares, sphincterotomes, spinal cord stimulator systems, stents: gastrointestinal, stents: pulmonary, stents: ureteral, stents: vascular, thrombectomy systems, transcatheter heart valve, ureteroscopes, uterine tissue removal systems, in this market focused portfolio is accessories The company is continuously engaged in strategic relationship to enhance the product and service of the inflation devices such as,
- In February 2019, Boston Scientific Corporation participated in SVB Leerink global healthcare conference, held at New York City and shared their views on healthcare. By this conference, the company increases their awareness about the business.
The company has various subsidiaries such as Guidant Global (U.K.), Augmenix, Inc. (U.K.), American Medical Systems, LLC (U.S.), Symetis SA (Switzerland), Claret Medical (U.S.), among others.
